PFE vs RMBS · P/E 20, rev $62.58B vs P/E 34, $7.08B cap
Pfizer Inc (PFE) versus Rambus Inc (RMBS) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Rambus Inc (RMBS) is a semiconductors company listed on US.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
RMBS does not have a complete income-statement cache yet.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. RMBS currently screens at market cap $7.08B and trailing P/E 34.5.
Not investment advice. Open the PFE and RMBS stock pages for the full models.
Not investment advice.